Department of Cardiology, Quebec Heart and Lung Institute, Laval University, Quebec City, Quebec, Canada.
Ann Thorac Surg. 2012 Feb;93(2):647-50. doi: 10.1016/j.athoracsur.2011.07.020.
A 78-year-old gentleman with a diagnosis of symptomatic severe xenograft aortic stenosis with multiple comorbidities was referred for transcatheter aortic valve implantation, that is, a "valve-in-valve" procedure. Transcatheter aortic valve implantation was performed by transapical approach using a balloon-expandable bioprosthesis. During valve deployment, the prosthesis moved toward the left ventricle and a second balloon-expandable valve was implanted within the first one-a "valve-in-valve-in-valve" to avoid further ventricular embolization of the first bioprosthesis. Echocardiography at hospital discharge showed a residual mean transvalvular gradient of 17 mm Hg and trivial paravalvular aortic regurgitation. At 1 year follow-up, the patient was in New York Heart Association functional class II.
一位 78 岁的男性,患有症状性严重异种移植物主动脉瓣狭窄,合并多种合并症,被转诊行经导管主动脉瓣植入术,即“瓣中瓣”手术。经心尖入路,使用球囊扩张式生物瓣进行经导管主动脉瓣植入术。在瓣膜展开过程中,假体向左侧心室移动,在第一个球囊扩张式瓣膜内植入第二个球囊扩张式瓣膜,即“瓣中瓣中瓣”,以避免第一个生物瓣进一步向心室栓塞。出院时的超声心动图显示残余平均跨瓣梯度为 17mmHg,微量瓣周主动脉瓣反流。1 年随访时,患者纽约心脏协会功能分级为 II 级。